During the past decade, Bausch & Lomb conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 10 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Bausch & Lomb" are "Myopia" (6 trials), "Healthy" (2 trials), "Inflammation" (2 trials), "Allergic Conjunctivitis" (1 trials) and "Astigmatism" (1 trials). Many other conditions were trialed in "Bausch & Lomb" in a lesser frequency.

Most popular intervention types in "Bausch & Lomb" are "Device" (11 trials) and "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "0.3% BOL-303242-X ophthalmic suspension" (1 trials), "1% BOL-303242-X ophthalmic suspension" (1 trials), "2% BOL-303242-X ophthalmic suspension" (1 trials), "2% BOL-303242-X ophthalmic suspension AM" (1 trials) and "2% BOL-303242-X ophthalmic suspension PM" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bausch & Lomb" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Bausch & Lomb". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Bausch & Lomb, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bausch & Lomb, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".